trk受体
原肌球蛋白受体激酶C
受体酪氨酸激酶
原肌球蛋白
癌症研究
基因
融合基因
原肌球蛋白受体激酶A
医学
受体
激酶
酪氨酸激酶
癌症
生物
原肌球蛋白受体激酶B
遗传学
生物信息学
神经营养素
血小板源性生长因子受体
神经营养因子
肌动蛋白
生长因子
作者
Alessio Amatu,Andrea Sartore‐Bianchi,Katia Bencardino,Elio Gregory Pizzutilo,Federica Tosi,Salvatore Siena
标识
DOI:10.1093/annonc/mdz383
摘要
The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases are encoded by NTRK genes and have a role in the development and normal functioning of the nervous system. Since the discovery of an oncogenic NTRK gene fusion in colorectal cancer in 1986, over 80 different fusion partner genes have been identified in a wide array of adult and paediatric tumours, providing actionable targets for targeted therapy. This review describes the normal function and physiology of TRK receptors and the biology behind NTRK gene fusions and how they act as oncogenic drivers in cancer. Finally, an overview of the incidence and prevalence of NTRK gene fusions in various types of cancers is discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI